Published in Tissue Eng Part A on May 08, 2013
Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. Tissue Eng Part A (2014) 1.01
Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing. Cell Tissue Res (2014) 0.94
Increased Survival and Function of Mesenchymal Stem Cell Spheroids Entrapped in Instructive Alginate Hydrogels. Stem Cells Transl Med (2016) 0.83
Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential. Ann Biomed Eng (2014) 0.83
Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior. Acta Biomater (2015) 0.83
A review of fibrin and fibrin composites for bone tissue engineering. Int J Nanomedicine (2017) 0.76
Lysophosphatidic Acid and Sphingosine-1-Phosphate: A Concise Review of Biological Function and Applications for Tissue Engineering. Tissue Eng Part B Rev (2015) 0.75
Matrix elasticity directs stem cell lineage specification. Cell (2006) 43.00
Mesenchymal stem cells as trophic mediators. J Cell Biochem (2006) 9.38
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface (2010) 2.69
Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev (2008) 2.61
Wnt signaling controls the fate of mesenchymal stem cells. Gene (2008) 1.92
Fibrin gels and their clinical and bioengineering applications. J R Soc Interface (2009) 1.86
The behavior of human mesenchymal stem cells in 3D fibrin clots: dependence on fibrinogen concentration and clot structure. Tissue Eng (2006) 1.57
Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci (2001) 1.51
Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J Cell Biochem (2005) 1.48
Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact (2007) 1.47
Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Exp Cell Res (2010) 1.43
Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. Tissue Eng (2006) 1.35
Growth of continuous bonelike mineral within porous poly(lactide-co-glycolide) scaffolds in vitro. J Biomed Mater Res (2000) 1.35
Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials (2005) 1.34
Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One (2012) 1.29
Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. J Craniomaxillofac Surg (2003) 1.18
Fibrin as a delivery system for therapeutic drugs and biomolecules. Tissue Eng Part B Rev (2009) 1.16
Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials (2008) 1.14
Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A (2010) 1.13
Modulation of 3D fibrin matrix stiffness by intrinsic fibrinogen-thrombin compositions and by extrinsic cellular activity. Tissue Eng Part A (2009) 1.07
Mineral coatings for temporally controlled delivery of multiple proteins. Adv Mater (2011) 1.06
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials (2005) 1.00
Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. J Biomed Mater Res A (2009) 1.00
Calcium and fibrin gel structure. Thromb Res (1983) 0.99
Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng Part A (2012) 0.98
The accelerating effect of calcium and other cations on the conversion of fibrinogen to fibrin. J Clin Invest (1954) 0.97
Supplementation of fibrin gels with sodium chloride enhances physical properties and ensuing osteogenic response. Acta Biomater (2010) 0.97
Microcarriers in the engineering of cartilage and bone. Trends Biotechnol (2006) 0.95
Orthotopic bone formation by implantation of apatite-coated poly(lactide-co-glycolide)/hydroxyapatite composite particulates and bone morphogenetic protein-2. J Biomed Mater Res A (2008) 0.94
Osteogenic comparison of expanded and uncultured adipose stromal cells. Cytotherapy (2010) 0.94
Growth of hydroxyapatite coatings on biodegradable polymer microspheres. ACS Appl Mater Interfaces (2009) 0.94
A comparison of fibrin sealants in relation to their in vitro and in vivo properties. Thromb Res (2003) 0.93
Fabrication and physical and biological properties of fibrin gel derived from human plasma. Biomed Mater (2007) 0.91
Factors influencing fibrin gel structure studied by flow measurement. Ann N Y Acad Sci (1983) 0.90
The control of anchorage-dependent cell behavior within a hydrogel/microcarrier system in an osteogenic model. Biomaterials (2009) 0.90
Designing bioactive delivery systems for tissue regeneration. Ann Biomed Eng (2010) 0.88
Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds. Biotechnol Bioeng (2011) 0.83
A composite scaffold of PLGA microspheres/fibrin gel for cartilage tissue engineering: fabrication, physical properties, and cell responsiveness. J Biomed Mater Res B Appl Biomater (2009) 0.77
Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells. PLoS One (2012) 1.29
Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Am J Vet Res (2010) 1.28
Proangiogenic potential of a collagen/bioactive glass substrate. Pharm Res (2007) 1.23
Osteogenesis and trophic factor secretion are influenced by the composition of hydroxyapatite/poly(lactide-co-glycolide) composite scaffolds. Tissue Eng Part A (2010) 1.13
The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials (2008) 1.07
Angiogenic response to bioactive glass promotes bone healing in an irradiated calvarial defect. Tissue Eng Part A (2009) 1.05
Influence of the oxygen microenvironment on the proangiogenic potential of human endothelial colony forming cells. Angiogenesis (2009) 1.04
Oxygen tension differentially influences osteogenic differentiation of human adipose stem cells in 2D and 3D cultures. J Cell Biochem (2010) 1.03
Design of experiments approach to engineer cell-secreted matrices for directing osteogenic differentiation. Ann Biomed Eng (2010) 1.02
Lysophosphatidic acid protects human mesenchymal stromal cells from differentiation-dependent vulnerability to apoptosis. Tissue Eng Part A (2014) 1.01
Biomimetic scaffolds fabricated from apatite-coated polymer microspheres. J Biomed Mater Res A (2009) 1.00
Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl Med (2014) 1.00
Bioceramic-mediated trophic factor secretion by mesenchymal stem cells enhances in vitro endothelial cell persistence and in vivo angiogenesis. Tissue Eng Part A (2012) 0.98
Noninvasive multimodal evaluation of bioengineered cartilage constructs combining time-resolved fluorescence and ultrasound imaging. Tissue Eng Part C Methods (2011) 0.96
Optimization of scaled-up chitosan microparticles for bone regeneration. Biomed Mater (2009) 0.96
Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing. Cell Tissue Res (2014) 0.94
Osteogenic comparison of expanded and uncultured adipose stromal cells. Cytotherapy (2010) 0.94
Remineralization of demineralized bone matrix (DBM) via alternating solution immersion (ASI). J Mech Behav Biomed Mater (2013) 0.93
The role of protein solubilization in antigen removal from xenogeneic tissue for heart valve tissue engineering. Biomaterials (2011) 0.93
Cell-derived matrix coatings for polymeric scaffolds. Tissue Eng Part A (2012) 0.92
Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration. J Biomed Mater Res A (2010) 0.92
Alginate hydrogels containing cell-interactive beads for bone formation. FASEB J (2013) 0.90
Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther (2007) 0.89
Advancements in electrospinning of polymeric nanofibrous scaffolds for tissue engineering. Tissue Eng Part B Rev (2013) 0.88
Designing bioactive delivery systems for tissue regeneration. Ann Biomed Eng (2010) 0.88
A reproducible, high throughput method for fabricating fibrin gels. BMC Res Notes (2012) 0.87
Mesenchymal stem cell function on hybrid organic/inorganic microparticles in vitro. J Tissue Eng Regen Med (2010) 0.86
Transferable cell-secreted extracellular matrices enhance osteogenic differentiation. Acta Biomater (2011) 0.86
Biomineralized composite substrates increase gene expression with nonviral delivery. J Biomed Mater Res A (2010) 0.84
Osteogenic response to BMP-2 of hMSCs grown on apatite-coated scaffolds. Biotechnol Bioeng (2011) 0.83
Engineered Fibrin Gels for Parallel Stimulation of Mesenchymal Stem Cell Proangiogenic and Osteogenic Potential. Ann Biomed Eng (2014) 0.83
Oxygen tension modulates neurite outgrowth in PC12 cells through a mechanism involving HIF and VEGF. J Mol Neurosci (2010) 0.82
Differential growth factor adsorption to calvarial osteoblast-secreted extracellular matrices instructs osteoblastic behavior. PLoS One (2011) 0.81
Lysophosphatidic acid enhances stromal cell-directed angiogenesis. PLoS One (2013) 0.80
Ultrastructure and growth factor content of equine platelet-rich fibrin gels. Am J Vet Res (2014) 0.78
Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications. Stem Cells Transl Med (2015) 0.77
Remineralized bone matrix as a scaffold for bone tissue engineering. J Biomed Mater Res A (2014) 0.77
Reduced serum and hypoxic culture conditions enhance the osteogenic potential of human mesenchymal stem cells. Stem Cell Rev (2015) 0.77
Extracellular Matrix-Coated Composite Scaffolds Promote Mesenchymal Stem Cell Persistence and Osteogenesis. Biomacromolecules (2016) 0.76
Synthetic extracellular matrices for tissue engineering. Pharm Res (2008) 0.76
Redirection of neurite outgrowth by coupling chondroitin sulfate proteoglycans to polymer membranes. Ann Biomed Eng (2014) 0.76
Factors affecting the particle size and in vitro release of bovine serum albumin from polyethylene glycol microparticles. Biomed Sci Instrum (2003) 0.76
Supersonic transient magnetic resonance elastography for quantitative assessment of tissue elasticity. Phys Med Biol (2017) 0.75
Functional genomics of apocarotenoids in saffron: insights from chemistry, molecular biology and therapeutic applications. Brief Funct Genomics (2017) 0.75
Cell Migration and Bone Formation from Mesenchymal Stem Cell Spheroids in Alginate Hydrogels are Regulated by Adhesive Ligand Density. Biomacromolecules (2017) 0.75
Binding to COMP Reduces the BMP2 Dose for Spinal Fusion in a Rat Model. Spine (Phila Pa 1976) (2016) 0.75